CSF3R and myeloid neoplasm: This diversity in mutation percentages highlights the complex clonal architecture of CSF3R-mutated myeloid neoplasms and emphasizes the importance of considering the broader mutational context when interpreting the role of CSF3R in disease pathogenesis and therapeutic decision-making.